Molecular Mechanisms in Pentanucleotide Repeat Diseases
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The number of neurodegenerative diseases resulting from repeat expansion has increased extraordinarily in recent years. In several of these pathologies, the repeat can be transcribed in RNA from both DNA strands producing, at least, one toxic RNA repeat that causes neurodegeneration by a complex mechanism. Recently, seven diseases have been found caused by a novel intronic pentanucleotide repeat in distinct genes encoding proteins highly expressed in the cerebellum. These disorders are clinically heterogeneous being characterized by impaired motor function, resulting from ataxia or epilepsy. The role that apparently normal proteins from these mutant genes play in these pathologies is not known. However, recent advances in previously known spinocerebellar ataxias originated by abnormal non-coding pentanucleotide repeats point to a gain of a toxic function by the pathogenic repeat-containing RNA that abnormally forms nuclear foci with RNA-binding proteins. In cells, RNA foci have been shown to be formed by phase separation. Moreover, the field of repeat expansions has lately achieved an extraordinary progress with the discovery that RNA repeats, polyglutamine, and polyalanine proteins are crucial for the formation of nuclear membraneless organelles by phase separation, which is perturbed when they are expanded. This review will cover the amazing advances on repeat diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“All these diseases are caused by the same or similar repeat motifs and related RNA-mediated mechanisms (Ishiura and Tsuji, 2020; Loureiro et al., 2022; Zhang and Ashizawa, 2022).”
From Embryonic spinocerebellar ataxia type 37-associated AUUUC repeat RNA causes neurodevelopmental defects (2026) · cites this paper as Loureiro et al., 2022
In the citing paper
“One of the pathogenic processes that seems to explain the cellular and neurological phenotypes associated with expanded RNA repeats is the abnormal binding and sequestration of RNA-binding proteins (RBPs), which trigger nuclear RNA aggregate formation and RBP loss-of-function”
From Embryonic spinocerebellar ataxia type 37-associated AUUUC repeat RNA causes neurodevelopmental defects (2026) · cites this paper as Loureiro et al., 2022
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1
Orr, H. T., Chung, M.-Y., Banfi, S., Kwiatkowski, T. J., Servadio, A., Beaudet, A. L., McCall, A. E., Duvick, L. A., Ranum, L. P. W., & Zoghbi, H. Y. (1993) · Nature Genetics · doi:10.1038/ng0793-221 · Cited by 1,632 · cited 16×
“In preclinical studies, non-allele specific ASOs acting by RNase-H degradation have been successful for SCA1 [171], SCA3 [173,174], SCA7 [177] and DM1 [178].”
InfluentialScrambler and yotari disrupt the disabled gene and produce a reeler -like phenotype in mice
Sheldon, M., Rice, D. S., D'Arcangelo, G., Yoneshima, H., Nakajima, K., Mikoshiba, K., Howell, B. W., Cooper, J. A., Goldowitz, D., & Curran, T. (1997) · Nature · doi:10.1038/39601 · Cited by 638 · cited 1×
“DAB1 encodes an adaptor protein of the reelin signaling pathway that controls accurate positioning of neurons and maturation of synaptic connections in the brain during development [127].”
BackgroundBiallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia
Cortese, A., Simone, R., Sullivan, R., Vandrovcova, J., Tariq, H., Yau, W. Y., Humphrey, J., Jaunmuktane, Z., Sivakumar, P., Polke, J., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0372-4 · Cited by 575 · cited 13×
“The disease-associated haplotype has been observed in carriers of two large (AAAGG)n alleles and of (AAGGG)exp/large (AAAGG)n chromosomes [32].”
BackgroundInfluentialJiang, J., Zhu, Q., Gendron, T. F., Saberi, S., McAlonis-Downes, M., Seelman, A., Stauffer, J. E., Jafar-nejad, P., Drenner, K., Schulte, D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.04.006 · Cited by 536 · cited 1×
“The most promising ASOs reached clinical trials phase I, being the case of ASOs BIIB105 (NCT04494256) for ALS, and both WVE-004 (NCT04931862) and BIIB078 (NCT03626012) for C9ORF72 FTD/ALS [172,179,180].”
Background30 years of repeat expansion disorders: What have we learned and what are the remaining challenges?
Depienne, C., & Mandel, J.-L. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.03.011 · Cited by 429 · cited 1×
“There are six known genetic types of FAME and they are all caused by (ATTTC)n insertions [140].”
BackgroundDetection of long repeat expansions from PCR-free whole-genome sequence data
Dolzhenko, E., van Vugt, J. J. F. A., Shaw, R. J., Bekritsky, M. A., van Blitterswijk, M., Narzisi, G., Ajay, S. S., Rajan, V., Lajoie, B. R., Johnson, N. H., et al. (2017) · Genome Research · doi:10.1101/gr.225672.117 · Cited by 388
Antisense oligonucleotide therapy for spinocerebellar ataxia type 2
Scoles, D. R., Meera, P., Schneider, M. D., Paul, S., Dansithong, W., Figueroa, K. P., Hung, G., Rigo, F., Bennett, C. F., Otis, T. S., et al. (2017) · Nature · doi:10.1038/nature22044 · Cited by 319
RNA Gain-of-Function in Spinocerebellar Ataxia Type 8
Daughters, R. S., Tuttle, D. L., Gao, W., Ikeda, Y., Moseley, M. L., Ebner, T. J., Swanson, M. S., & Ranum, L. P. W. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000600 · Cited by 278
Rafehi, H., Szmulewicz, D. J., Bennett, M. F., Sobreira, N. L. M., Pope, K., Smith, K. R., Gillies, G., Diakumis, P., Dolzhenko, E., Eberle, M. A., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.05.016 · Cited by 262
Research works printed but not linked: 174
- Malik, 2021, Author Correction: Molecular mechanisms underlying nucleotide repeat expansion disorders, Nat. Rev. Mol. Cell Biol., 22, 644, 10.1038/s41580-021-00396-0 · doi:10.1038/s41580-021-00396-0
- Morriss, 2017, Protein sequestration as a normal function of long noncoding RNAs and a pathogenic mechanism of RNAs containing nucleotide repeat expansions, Hum. Genet., 136, 1247, 10.1007/s00439-017-1807-6 · DOI
- Basu, 2020, Unblending of Transcriptional Condensates in Human Repeat Expansion Disease, Cell, 181, 1062, 10.1016/j.cell.2020.04.018 · DOI · Paper page
- Paul, 2018, Staufen1 links RNA stress granules and autophagy in a model of neurodegeneration, Nat. Commun., 9, 3648, 10.1038/s41467-018-06041-3 · DOI
- Loureiro, 2016, Unstable repeat expansions in neurodegenerative diseases: Nucleocytoplasmic transport emerges on the scene, Neurobiol. Aging, 39, 174, 10.1016/j.neurobiolaging.2015.12.007 · DOI
- Nguyen, 2019, Repeat-Associated Non-ATG Translation: Molecular Mechanisms and Contribution to Neurological Disease, Annu. Rev. Neurosci., 42, 227, 10.1146/annurev-neuro-070918-050405 · DOI
- Sznajder, L.J., and Swanson, M.S. (2019). Short Tandem Repeat Expansions and RNA-Mediated Pathogenesis in Myotonic Dystrophy. Int. J. Mol. Sci., 20. · DOI · Paper page
- Lalioti, 1997, Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy, Nature, 386, 847, 10.1038/386847a0 · DOI · Paper page
- LaCroix, 2019, GGC Repeat Expansion and Exon 1 Methylation of XYLT1 Is a Common Pathogenic Variant in Baratela-Scott Syndrome, Am. J. Hum. Genet., 104, 35, 10.1016/j.ajhg.2018.11.005 · DOI · Paper page
- Holmes, 1999, Expansion of a novel CAG trinucleotide repeat in the 5′ region of PPP2R2B is associated with SCA12, Nat. Genet., 23, 391, 10.1038/70493 · DOI · Paper page
- Hwang, 2015, Neuropathology and Cellular Pathogenesis of Spinocerebellar Ataxia Type 12, Mov. Disord., 30, 1813, 10.1002/mds.26348 · DOI
- Verkerk, 1991, Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome, Cell, 65, 905, 10.1016/0092-8674(91)90397-H · DOI · Paper page
- Knight, 1993, Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation, Cell, 74, 127, 10.1016/0092-8674(93)90300-F · DOI · Paper page
- Metsu, S., Rooms, L., Rainger, J., Taylor, M.S., Bengani, H., Wilson, D.I., Chilamakuri, C.S., Morrison, H., Vandeweyer, G., and Reyniers, E. (2014). FRA2A is a CGG repeat expansion associated with silencing of AFF3. PLoS Genet., 10. · DOI
- Metsu, 2014, A CGG-repeat expansion mutation in ZNF713 causes FRA7A: Association with autistic spectrum disorder in two families, Hum. Mutat., 35, 1295
- Debacker, 2007, The molecular basis of the folate-sensitive fragile site FRA11A at 11q13, Cytogenet. Genome Res., 119, 9, 10.1159/000109612 · DOI
- Winnepenninckx, 2007, CGG-repeat expansion in the DIP2B gene is associated with the fragile site FRA12A on chromosome 12q13.1, Am. J. Hum. Genet., 80, 221, 10.1086/510800 · DOI · Paper page
- Richmond, 2019, Glutaminase Deficiency Caused by Short Tandem Repeat Expansion in GLS, N. Engl. J. Med., 380, 1433, 10.1056/NEJMoa1806627 · DOI · Paper page
- Hagerman, 2001, Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X, Neurology, 57, 127, 10.1212/WNL.57.1.127 · DOI · Paper page
- Cronister, 1991, Heterozygous fragile X female: Historical, physical, cognitive, and cytogenetic features, Am. J. Med. Genet., 38, 269, 10.1002/ajmg.1320380221 · DOI · Paper page
- Tian, 2019, Expansion of Human-Specific GGC Repeat in Neuronal Intranuclear Inclusion Disease-Related Disorders, Am. J. Hum. Genet., 105, 166, 10.1016/j.ajhg.2019.05.013 · DOI · Paper page
- Sone, 2019, Long-read sequencing identifies GGC repeat expansions in NOTCH2NLC associated with neuronal intranuclear inclusion disease, Nat. Genet., 51, 1215, 10.1038/s41588-019-0459-y · DOI · Paper page
- Ishiura, 2019, Noncoding CGG repeat expansions in neuronal intranuclear inclusion disease, oculopharyngodistal myopathy and an overlapping disease, Nat. Genet., 51, 1222, 10.1038/s41588-019-0458-z · DOI · Paper page
- Campuzano, 1996, Friedreich’s ataxia: Autosomal recessive disease caused by an intronic GAA triplet repeat expansion, Science, 271, 1423, 10.1126/science.271.5254.1423 · DOI · Paper page
- Mackenzie, 2011, Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS, Neuron, 72, 245, 10.1016/j.neuron.2011.09.011 · DOI · Paper page
- Renton, 2011, A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD, Neuron, 72, 257, 10.1016/j.neuron.2011.09.010 · DOI · Paper page
- Matsuura, 2000, Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10, Nat. Genet., 26, 191, 10.1038/79911 · DOI · Paper page
- Quintans, 2012, ‘Costa da Morte’ ataxia is spinocerebellar ataxia 36: Clinical and genetic characterization, Brain, 135, 1423, 10.1093/brain/aws069 · DOI · Paper page
- Kobayashi, 2011, Expansion of intronic GGCCTG hexanucleotide repeat in NOP56 causes SCA36, a type of spinocerebellar ataxia accompanied by motor neuron involvement, Am. J. Hum. Genet., 89, 121, 10.1016/j.ajhg.2011.05.015 · DOI · Paper page
- Liquori, 2001, Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9, Science, 293, 864, 10.1126/science.1062125 · DOI · Paper page
- Wieben, E.D., Aleff, R.A., Tosakulwong, N., Butz, M.L., Highsmith, W.E., Edwards, A.O., and Baratz, K.H. (2012). A common trinucleotide repeat expansion within the transcription factor 4 (TCF4, E2-2) gene predicts Fuchs corneal dystrophy. PLoS ONE, 7. · DOI · Paper page
- Sato, 2009, Spinocerebellar ataxia type 31 is associated with “inserted” penta-nucleotide repeats containing (TGGAA)n, Am. J. Hum. Genet., 85, 544, 10.1016/j.ajhg.2009.09.019 · DOI · Paper page
- Seixas, 2017, A Pentanucleotide ATTTC Repeat Insertion in the Non-coding Region of DAB1, Mapping to SCA37, Causes Spinocerebellar Ataxia, Am. J. Hum. Genet., 101, 87, 10.1016/j.ajhg.2017.06.007 · DOI · Paper page
- Ishiura, 2018, Expansions of intronic TTTCA and TTTTA repeats in benign adult familial myoclonic epilepsy, Nat. Genet., 50, 581, 10.1038/s41588-018-0067-2 · DOI · Paper page
- Corbett, 2019, Intronic ATTTC repeat expansions in STARD7 in familial adult myoclonic epilepsy linked to chromosome 2, Nat. Commun., 10, 4920, 10.1038/s41467-019-12671-y · DOI · Paper page
- Florian, 2019, Unstable TTTTA/TTTCA expansions in MARCH6 are associated with Familial Adult Myoclonic Epilepsy type 3, Nat. Commun., 10, 4919, 10.1038/s41467-019-12763-9 · DOI · Paper page
- Yeetong, 2019, TTTCA repeat insertions in an intron of YEATS2 in benign adult familial myoclonic epilepsy type 4, Brain, 142, 3360, 10.1093/brain/awz267 · DOI
- Bragg, 2017, Disease onset in X-linked dystonia-parkinsonism correlates with expansion of a hexameric repeat within an SVA retrotransposon in TAF1, Proc. Natl. Acad. Sci. USA, 114, E11020, 10.1073/pnas.1712526114 · DOI · Paper page
- Mahadevan, 1992, Myotonic dystrophy mutation: An unstable CTG repeat in the 3′ untranslated region of the gene, Science, 255, 1253, 10.1126/science.1546325 · DOI · Paper page
- Brook, 1992, Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member, Cell, 68, 799, 10.1016/0092-8674(92)90154-5 · DOI · Paper page
- Seixas, 2012, Loss of junctophilin-3 contributes to huntington disease-like 2 pathogenesis, Ann. Neurol., 71, 245, 10.1002/ana.22598 · DOI · Paper page
- Wilburn, 2011, An antisense CAG repeat transcript at JPH3 locus med.diates expanded polyglutamine protein toxicity in Huntington’s disease-like 2 mice, Neuron, 70, 427, 10.1016/j.neuron.2011.03.021 · DOI · Paper page
- Holmes, 2001, A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2, Nat. Genet., 29, 377, 10.1038/ng760 · DOI · Paper page
- Koob, 1999, An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8), Nat. Genet., 21, 379, 10.1038/7710 · DOI · Paper page
- Moseley, 2006, Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8, Nat. Genet., 38, 758, 10.1038/ng1827 · DOI · Paper page
- Koide, 1994, Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA), Nat. Genet., 6, 9, 10.1038/ng0194-9 · DOI · Paper page
- The Huntington’s Disease Collaborative Research Group (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell, 72, 971–983. · DOI · Paper page
- Wilson, 1991, Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy, Nature, 352, 77, 10.1038/352077a0 · DOI · Paper page
- Imbert, 1996, Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats, Nat. Genet., 14, 285, 10.1038/ng1196-285 · DOI · Paper page
- Kawaguchi, 1994, CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1, Nat. Genet., 8, 221, 10.1038/ng1194-221 · DOI · Paper page
- Zhuchenko, 1997, Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel, Nat. Genet., 15, 62, 10.1038/ng0197-62 · DOI · Paper page
- Lindblad, 1996, An expanded CAG repeat sequence in spinocerebellar ataxia type 7, Genome Res., 6, 965, 10.1101/gr.6.10.965 · DOI · Paper page
- Koide, 1999, A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: A new polyglutamine disease?, Hum. Mol. Genet., 8, 2047, 10.1093/hmg/8.11.2047 · DOI · Paper page
- Brais, 1998, Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy, Nat. Genet., 18, 164, 10.1038/ng0298-164 · DOI · Paper page
- Stromme, 2002, Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy, Nat. Genet., 30, 441, 10.1038/ng862 · DOI · Paper page
- Beysen, 2003, FOXL2 and BPES: Mutational hotspots, phenotypic variability, and revision of the genotype-phenotype correlation, Am. J. Hum. Genet., 72, 478, 10.1086/346118 · DOI · Paper page
- Mundlos, 1997, Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia, Cell, 89, 773, 10.1016/S0092-8674(00)80260-3 · DOI · Paper page
- Amiel, 2003, Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome, Nat. Genet., 33, 459, 10.1038/ng1130 · DOI · Paper page
- Goodman, 2000, Novel HOXA13 mutations and the phenotypic spectrum of hand-foot-genital syndrome, Am. J. Hum. Genet., 67, 197, 10.1086/302961 · DOI · Paper page
- Brown, 1998, Holoprosencephaly due to mutations in ZIC2, a homologue of Drosophila odd-paired, Nat. Genet., 20, 180, 10.1038/2484 · DOI · Paper page
- Muragaki, 1996, Altered growth and branching patterns in synpolydactyly caused by mutations in HOXD13, Science, 272, 548, 10.1126/science.272.5261.548 · DOI · Paper page
- Kato, 2004, Mutations of ARX are associated with striking pleiotropy and consistent genotype-phenotype correlation, Hum. Mutat., 23, 147, 10.1002/humu.10310 · DOI · Paper page
- Laumonnier, 2002, Transcription factor SOX3 is involved in X-linked mental retardation with growth hormone deficiency, Am. J. Hum. Genet., 71, 1450, 10.1086/344661 · DOI · Paper page
- McLoughlin, 2019, Pathogenesis of SCA3 and implications for other polyglutamine diseases, Neurobiol. Dis., 134, 104635, 10.1016/j.nbd.2019.104635 · DOI · Paper page
- Rouleau, 2007, Oculopharyngeal muscular dystrophy: Recent advances in the understanding of the molecular pathogenic mechanisms and treatment strategies, Biochim. Biophys. Acta, 1772, 173, 10.1016/j.bbadis.2006.10.003 · DOI
- Hughes, 2013, Molecular pathology of polyalanine expansion disorders: New perspectives from mouse models, Methods Mol. Biol., 1017, 135, 10.1007/978-1-62703-438-8_10 · DOI
- Massey, 2018, The central role of DNA damage and repair in CAG repeat diseases, Dis. Model. Mech., 11, dmm031930, 10.1242/dmm.031930 · DOI
- Quinodoz, 2021, RNA promotes the formation of spatial compartments in the nucleus, Cell, 184, 5775, 10.1016/j.cell.2021.10.014 · DOI · Paper page
- Wiedner, 2021, It’s not just a phase: Function and characteristics of RNA-binding proteins in phase separation, Nat. Struct. Mol. Biol., 28, 465, 10.1038/s41594-021-00601-w · DOI · Paper page
- Nelson, 2013, The unstable repeats—Three evolving faces of neurological disease, Neuron, 77, 825, 10.1016/j.neuron.2013.02.022 · DOI · Paper page
- Li, 2015, Expanded GAA repeats impede transcription elongation through the FXN gene and induce transcriptional silencing that is restricted to the FXN locus, Hum. Mol. Genet., 24, 6932
- Mankodi, 2000, Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat, Science, 289, 1769, 10.1126/science.289.5485.1769 · DOI · Paper page
- Lee, 2013, Compound loss of muscleblind-like function in myotonic dystrophy, EMBO Mol. Med., 5, 1887, 10.1002/emmm.201303275 · DOI · Paper page
- Jain, 2017, RNA phase transitions in repeat expansion disorders, Nature, 546, 243, 10.1038/nature22386 · doi:10.1038/nature22386
- Hall, 2016, RNA as a fundamental component of interphase chromosomes: Could repeats prove key?, Curr. Opin. Genet. Dev., 37, 137, 10.1016/j.gde.2016.04.005 · DOI
- Zu, 2011, Non-ATG-initiated translation directed by microsatellite expansions, Proc. Natl. Acad. Sci. USA, 108, 260, 10.1073/pnas.1013343108 · DOI · Paper page
- Cleary, 2018, Repeat-associated non-ATG (RAN) translation, J. Biol. Chem., 293, 16127, 10.1074/jbc.R118.003237 · DOI
- Cho, 2005, Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF, Mol. Cell, 20, 483, 10.1016/j.molcel.2005.09.002 · DOI · Paper page
- Ladd, 2007, An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals, Hum. Mol. Genet., 16, 3174, 10.1093/hmg/ddm293 · DOI · Paper page
- Zu, 2013, RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia, Proc. Natl. Acad. Sci. USA, 110, E4968, 10.1073/pnas.1315438110 · DOI · Paper page
- Castro, A.F., Loureiro, J.R., Bessa, J., and Silveira, I. (2020). Antisense Transcription across Nucleotide Repeat Expansions in Neurodegenerative and Neuromuscular Diseases: Progress and Mysteries. Genes, 11. · DOI
- Plys, 2018, Dynamic condensates activate transcription, Science, 361, 329, 10.1126/science.aau4795 · DOI
- Ishikawa, 2019, Molecular Mechanisms and Future Therapeutics for Spinocerebellar Ataxia Type 31 (SCA31), Neurotherapeutics, 16, 1106, 10.1007/s13311-019-00804-6 · DOI
- Loureiro, 2019, Mutational mechanism for DAB1 (ATTTC)n insertion in SCA37: ATTTT repeat lengthening and nucleotide substitution, Hum. Mutat., 40, 404, 10.1002/humu.23704 · DOI
- Klockgether, 2019, Spinocerebellar ataxia, Nat. Rev. Dis. Primers, 5, 24, 10.1038/s41572-019-0074-3 · DOI · Paper page
- Huang, 2019, Why do so many genetic insults lead to Purkinje Cell degeneration and spinocerebellar ataxia?, Neurosci. Lett., 688, 49, 10.1016/j.neulet.2018.02.004 · DOI
- Buijsen, 2019, Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias, Neurotherapeutics, 16, 263, 10.1007/s13311-018-00696-y · DOI
- Lin, 2003, SCA10 and ATTCT repeat expansion: Clinical features and molecular aspects, Cytogenet. Genome Res., 100, 184, 10.1159/000072853 · DOI
- Teive, 2004, Clinical phenotype of Brazilian families with spinocerebellar ataxia 10, Neurology, 63, 1509, 10.1212/01.WNL.0000142109.62056.57 · doi:10.1212/01.wnl.0000142109.62056.57
- Alonso, 2006, Reduced penetrance of intermediate size alleles in spinocerebellar ataxia type 10, Neurology, 66, 1602, 10.1212/01.wnl.0000216266.30177.bb · doi:10.1212/01.wnl.0000216266.30177.bb
- Rasmussen, 2001, Clinical and genetic analysis of four Mexican families with spinocerebellar ataxia type 10, Ann. Neurol., 50, 234, 10.1002/ana.1081 · DOI
- Almeida, T., Alonso, I., Martins, S., Ramos, E.M., Azevedo, L., Ohno, K., Amorim, A., Saraiva-Pereira, M.L., Jardim, L.B., and Matsuura, T. (2009). Ancestral origin of the ATTCT repeat expansion in spinocerebellar ataxia type 10 (SCA10). PLoS ONE, 4. · DOI
- Bushara, K., Bower, M., Liu, J., McFarland, K.N., Landrian, I., Hutter, D., Teive, H.A., Rasmussen, A., Mulligan, C.J., and Ashizawa, T. (2013). Expansion of the Spinocerebellar ataxia type 10 (SCA10) repeat in a patient with Sioux Native American ancestry. PLoS ONE, 8. · DOI
- Leonardi, 2014, Spinocerebellar ataxia type 10 in Peru: The missing link in the Amerindian origin of the disease, J. Neurol., 261, 1691, 10.1007/s00415-014-7394-8 · DOI
- Xia, 2015, Bolivian kindred with combined spinocerebellar ataxia types 2 and 10, Acta Neurol. Scand., 132, 139, 10.1111/ane.12371 · doi:10.1111/ane.12371
- Castilhos, 2020, Genetic Analysis of Hereditary Ataxias in Peru Identifies SCA10 Families with Incomplete Penetrance, Cerebellum, 19, 208, 10.1007/s12311-019-01098-2 · DOI
- Wang, 2015, Spinocerebellar ataxia type 10 in Chinese Han, Neurol. Genet., 1, e26, 10.1212/NXG.0000000000000026 · doi:10.1212/nxg.0000000000000026
- Naito, H., Takahashi, T., Kamada, M., Morino, H., Yoshino, H., Hattori, N., Maruyama, H., Kawakami, H., and Matsumoto, M. (2017). First report of a Japanese family with spinocerebellar ataxia type 10: The second report from Asia after a report from China. PLoS ONE, 12. · DOI
- Waragai, 2006, Ataxin 10 induces neuritogenesis via interaction with G-protein beta2 subunit, J. Neurosci. Res., 83, 1170, 10.1002/jnr.20807 · DOI
- Matsuura, 2006, Interruptions in the expanded ATTCT repeat of spinocerebellar ataxia type 10: Repeat purity as a disease modifier?, Am. J. Hum. Genet., 78, 125, 10.1086/498654 · DOI
- McFarland, K.N., Liu, J., Landrian, I., Godiska, R., Shanker, S., Yu, F., Farmerie, W.G., and Ashizawa, T. (2015). SMRT Sequencing of Long Tandem Nucleotide Repeats in SCA10 Reveals Unique Insight of Repeat Expansion Structure. PLoS ONE, 10. · DOI
- McFarland, 2014, Repeat interruptions in spinocerebellar ataxia type 10 expansions are strongly associated with epileptic seizures, Neurogenetics, 15, 59, 10.1007/s10048-013-0385-6 · doi:10.1007/s10048-013-0385-6
- Hashem, V., Tiwari, A., Bewick, B., Teive, H.A.G., Moscovich, M., Schuele, B., Bushara, K., Bower, M., Rasmussen, A., and Tsai, Y.C. (2020). Pulse-Field capillary electrophoresis of repeat-primed PCR amplicons for analysis of large repeats in Spinocerebellar Ataxia Type 10. PLoS ONE, 15. · doi:10.1371/journal.pone.0231746
- Kurosaki, 2009, Alu-mediated acquisition of unstable ATTCT pentanucleotide repeats in the human ATXN10 gene, Mol. Biol. Evol., 26, 2573, 10.1093/molbev/msp172 · DOI
- Wakamiya, 2006, The role of ataxin 10 in the pathogenesis of spinocerebellar ataxia type 10, Neurology, 67, 607, 10.1212/01.wnl.0000231140.26253.eb · DOI
- White, M.C., Gao, R., Xu, W., Mandal, S.M., Lim, J.G., Hazra, T.K., Wakamiya, M., Edwards, S.F., Raskin, S., and Teive, H.A. (2010). Inactivation of hnRNP K by expanded intronic AUUCU repeat induces apoptosis via translocation of PKCdelta to mitochondria in spinocerebellar ataxia 10. PLoS Genet., 6. · DOI · Paper page
- White, 2012, Transgenic mice with SCA10 pentanucleotide repeats show motor phenotype and susceptibility to seizure: A toxic RNA gain-of-function model, J. Neurosci. Res., 90, 706, 10.1002/jnr.22786 · doi:10.1002/jnr.22786
- Ishikawa, 2011, Pentanucleotide repeats at the spinocerebellar ataxia type 31 (SCA31) locus in Caucasians, Neurology, 77, 1853, 10.1212/WNL.0b013e3182377e3a · DOI
- Sakai, 2010, Analysis of an insertion mutation in a cohort of 94 patients with spinocerebellar ataxia type 31 from Nagano, Japan, Neurogenetics, 11, 409, 10.1007/s10048-010-0245-6 · doi:10.1007/s10048-010-0245-6
- Yoshida, 2017, Inter-generational instability of inserted repeats during transmission in spinocerebellar ataxia type 31, J. Hum. Genet., 62, 923, 10.1038/jhg.2017.63 · doi:10.1038/jhg.2017.63
- Lee, 2012, SCA31 is rare in the Chinese population on Taiwan, Neurobiol. Aging, 33, 426.e23, 10.1016/j.neurobiolaging.2010.10.012 · doi:10.1016/j.neurobiolaging.2010.10.012
- Ouyang, 2012, Spinocerebellar ataxia type 31 exists in northeast China, J. Neurol. Sci., 316, 164, 10.1016/j.jns.2012.02.005 · doi:10.1016/j.jns.2012.02.005
- Niimi, 2013, Abnormal RNA structures (RNA foci) containing a penta-nucleotide repeat (UGGAA)n in the Purkinje cell nucleus is associated with spinocerebellar ataxia type 31 pathogenesis, Neuropathology, 33, 600, 10.1111/neup.12032 · DOI
- Ishiguro, 2017, Regulatory Role of RNA Chaperone TDP-43 for RNA Misfolding and Repeat-Associated Translation in SCA31, Neuron, 94, 108, 10.1016/j.neuron.2017.02.046 · DOI · Paper page
- Shibata, 2021, Small molecule targeting r(UGGAA)n disrupts RNA foci and alleviates disease phenotype in Drosophila model, Nat. Commun., 12, 236, 10.1038/s41467-020-20487-4 · DOI
- Ninomiya, 2020, LncRNA-dependent nuclear stress bodies promote intron retention through SR protein phosphorylation, EMBO J., 39, e102729, 10.15252/embj.2019102729 · DOI · Paper page
- Loureiro, 2018, A repeat-primed PCR assay for pentanucleotide repeat alleles in spinocerebellar ataxia type 37, J. Hum. Genet., 63, 981, 10.1038/s10038-018-0474-3 · doi:10.1038/s10038-018-0474-3
- Stevanin, 2013, New subtype of spinocerebellar ataxia with altered vertical eye movements mapping to chromosome 1p32, JAMA Neurol., 70, 764, 10.1001/jamaneurol.2013.2311 · DOI
- Rabano, 2018, Clinical, genetic and neuropathological characterization of spinocerebellar ataxia type 37, Brain, 141, 1981, 10.1093/brain/awy137 · DOI · Paper page
- Chung, 1993, Evidence for a mechanism predisposing to intergenerational CAG repeat instability in spinocerebellar ataxia type I, Nat. Genet., 5, 254, 10.1038/ng1193-254 · DOI · Paper page
- Ramos, 2010, Common Origin of Pure and Interrupted Repeat Expansions in Spinocerebellar Ataxia Type 2 (SCA2), Am. J. Med. Genet. Part B Neuropsychiatr. Genet., 153B, 524, 10.1002/ajmg.b.31013 · doi:10.1002/ajmg.b.31013
- Liquori, 2003, Myotonic dystrophy type 2: Human founder haplotype and evolutionary conservation of the repeat tract, Am. J. Hum. Genet., 73, 849, 10.1086/378720 · DOI
- Szmulewicz, 2016, Proposed diagnostic criteria for cerebellar ataxia with neuropathy and vestibular areflexia syndrome (CANVAS), Neurol. Clin. Pract., 6, 61, 10.1212/CPJ.0000000000000215 · DOI
- Akcimen, 2019, Investigation of the RFC1 Repeat Expansion in a Canadian and a Brazilian Ataxia Cohort: Identification of Novel Conformations, Front. Genet., 10, 1219, 10.3389/fgene.2019.01219 · DOI
- Scriba, 2020, A novel RFC1 repeat motif (ACAGG) in two Asia-Pacific CANVAS families, Brain, 143, 2904, 10.1093/brain/awaa263 · DOI
- Beecroft, 2020, A Maori specific RFC1 pathogenic repeat configuration in CANVAS, likely due to a founder allele, Brain, 143, 2673, 10.1093/brain/awaa203 · DOI
- Kurosaki, T., Ueda, S., Ishida, T., Abe, K., Ohno, K., and Matsuura, T. (2012). The unstable CCTG repeat responsible for myotonic dystrophy type 2 originates from an AluSx element insertion into an early primate genome. PLoS ONE, 7. · DOI
- Pastore, 2013, Frataxin: A protein in search for a function, J. Neurochem., 126, 43, 10.1111/jnc.12220 · DOI · Paper page
- Sharifi, 2018, Familial Cortical Myoclonic Tremor and Epilepsy, an Enigmatic Disorder: From Phenotypes to Pathophysiology and Genetics. A Systematic Review, Tremor Other Hyperkinet. Mov., 8, 503, 10.5334/tohm.434 · DOI
- Depienne, 2010, Familial cortical myoclonic tremor with epilepsy: The third locus (FCMTE3) maps to 5p, Neurology, 74, 2000, 10.1212/WNL.0b013e3181e396a8 · DOI
- Striano, 2009, 1H-MR spectroscopy indicates prominent cerebellar dysfunction in benign adult familial myoclonic epilepsy, Epilepsia, 50, 1491, 10.1111/j.1528-1167.2008.01900.x · doi:10.1111/j.1528-1167.2008.01900.x
- Bour, 2007, Decreased cortical inhibition and yet cerebellar pathology in ‘familial cortical myoclonic tremor with epilepsy’, Mov. Disord., 22, 2378, 10.1002/mds.21738 · DOI
- Buijink, 2016, Cerebellar Atrophy in Cortical Myoclonic Tremor and Not in Hereditary Essential Tremor-a Voxel-Based Morphometry Study, Cerebellum, 15, 696, 10.1007/s12311-015-0734-0 · DOI
- Striano, 2013, Autosomal dominant cortical tremor, myoclonus, and epilepsy: Is the origin in the cerebellum? Editorial, Cerebellum, 12, 145, 10.1007/s12311-012-0419-x · doi:10.1007/s12311-012-0419-x
- Mikami, 1999, Localization of a gene for benign adult familial myoclonic epilepsy to chromosome 8q23.3-q24.1, Am. J. Hum. Genet., 65, 745, 10.1086/302535 · DOI · Paper page
- Plaster, 1999, Genetic localization of the familial adult myoclonic epilepsy (FAME) gene to chromosome 8q24, Neurology, 53, 1180, 10.1212/WNL.53.6.1180 · DOI
- Cen, 2018, Intronic pentanucleotide TTTCA repeat insertion in the SAMD12 gene causes familial cortical myoclonic tremor with epilepsy type 1, Brain, 141, 2280, 10.1093/brain/awy160 · DOI
- Cen, 2019, Intronic (TTTGA)n insertion in SAMD12 also causes familial cortical myoclonic tremor with epilepsy, Mov. Disord., 34, 1571, 10.1002/mds.27832 · DOI
- Lei, 2019, TTTCA repeat expansion causes familial cortical myoclonic tremor with epilepsy, Eur. J. Neurol., 26, 513, 10.1111/ene.13848 · DOI
- Zeng, 2019, Long-read sequencing identified intronic repeat expansions in SAMD12 from Chinese pedigrees affected with familial cortical myoclonic tremor with epilepsy, J. Med. Genet., 56, 265, 10.1136/jmedgenet-2018-105484 · DOI · Paper page
- Mizuguchi, 2019, Detecting a long insertion variant in SAMD12 by SMRT sequencing: Implications of long-read whole-genome sequencing for repeat expansion diseases, J. Hum. Genet., 64, 191, 10.1038/s10038-018-0551-7 · DOI
- Bennett, 2020, Familial adult myoclonic epilepsy type 1 SAMD12 TTTCA repeat expansion arose 17,000 years ago and is present in Sri Lankan and Indian families, Eur. J. Hum. Genet., 28, 973, 10.1038/s41431-020-0606-z · DOI
- Yeetong, 2021, Founder effect of the TTTCA repeat insertions in SAMD12 causing BAFME1, Eur. J. Hum. Genet., 29, 343, 10.1038/s41431-020-00729-1 · doi:10.1038/s41431-020-00729-1
- Guerrini, 2001, Autosomal dominant cortical myoclonus and epilepsy (ADCME) with complex partial and generalized seizures: A newly recognized epilepsy syndrome with linkage to chromosome 2p11.1-q12.2, Brain, 124, 2459, 10.1093/brain/124.12.2459 · DOI · Paper page
- Henden, 2016, Identity by descent fine mapping of familial adult myoclonus epilepsy (FAME) to 2p11.2-2q11.2, Hum. Genet., 135, 1117, 10.1007/s00439-016-1700-8 · DOI
- Bouteiller, 2008, Refinement of the 2p11.1-q12.2 locus responsible for cortical tremor associated with epilepsy and exclusion of candidate genes, Neurogenetics, 9, 69, 10.1007/s10048-007-0107-z · doi:10.1007/s10048-007-0107-z
- Tankard, 2018, Detecting Expansions of Tandem Repeats in Cohorts Sequenced with Short-Read Sequencing Data, Am. J. Hum. Genet., 103, 858, 10.1016/j.ajhg.2018.10.015 · DOI · Paper page
- Dashnow, 2018, STRetch: Detecting and discovering pathogenic short tandem repeat expansions, Genome Biol., 19, 121, 10.1186/s13059-018-1505-2 · DOI · Paper page
- Doi, 2014, Rapid detection of expanded short tandem repeats in personal genomics using hybrid sequencing, Bioinformatics, 30, 815, 10.1093/bioinformatics/btt647 · DOI
- Yeetong, 2013, A newly identified locus for benign adult familial myoclonic epilepsy on chromosome 3q26.32-3q28, Eur. J. Hum. Genet., 21, 225, 10.1038/ejhg.2012.133 · doi:10.1038/ejhg.2012.133
- Lander, 2001, Initial sequencing and analysis of the human genome, Nature, 409, 860, 10.1038/35057062 · DOI · Paper page
- Deininger, 2011, Alu elements: Know the SINEs, Genome Biol., 12, 236, 10.1186/gb-2011-12-12-236 · DOI · Paper page
- Kelkar, 2011, A matter of life or death: How microsatellites emerge in and vanish from the human genome, Genome Res., 21, 2038, 10.1101/gr.122937.111 · DOI
- Clark, 2004, Expansion of GAA triplet repeats in the human genome: Unique origin of the FRDA mutation at the center of an Alu, Genomics, 83, 373, 10.1016/j.ygeno.2003.09.001 · DOI
- Chen, 2017, ALUternative Regulation for Gene Expression, Trends Cell Biol., 27, 480, 10.1016/j.tcb.2017.01.002 · DOI
- Lubelsky, 2018, Sequences enriched in Alu repeats drive nuclear localization of long RNAs in human cells, Nature, 555, 107, 10.1038/nature25757 · DOI · Paper page
- Hammond, 2021, Delivery of oligonucleotide-based therapeutics: Challenges and opportunities, EMBO Mol. Med., 13, e13243, 10.15252/emmm.202013243 · DOI · Paper page
- Crooke, 2021, Antisense technology: A review, J. Biol. Chem., 296, 100416, 10.1016/j.jbc.2021.100416 · DOI · Paper page
- Scoles, 2019, Antisense oligonucleotides: A primer, Neurol. Genet., 5, e323, 10.1212/NXG.0000000000000323 · DOI · Paper page
- Silva, 2020, Antisense oligonucleotide therapeutics in neurodegenerative diseases: The case of polyglutamine disorders, Brain, 143, 407, 10.1093/brain/awz328 · DOI · Paper page
- Kuijper, 2021, Opportunities and challenges for antisense oligonucleotide therapies, J. Inherit. Metab. Dis., 44, 72, 10.1002/jimd.12251 · DOI
- Oliveira, 2015, Recent advances in characterization of nonviral vectors for delivery of nucleic acids: Impact on their biological performance, Expert Opin. Drug Deliv., 12, 27, 10.1517/17425247.2014.945421 · DOI
- Evers, 2015, Antisense oligonucleotides in therapy for neurodegenerative disorders, Adv. Drug Deliv. Rev., 87, 90, 10.1016/j.addr.2015.03.008 · DOI · Paper page
- Friedrich, 2018, Antisense oligonucleotide-mediated ataxin-1 reduction prolongs survival in SCA1 mice and reveals disease-associated transcriptome profiles, JCI Insight, 3, e123193, 10.1172/jci.insight.123193 · DOI · Paper page
- McLoughlin, 2018, Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice, Ann. Neurol., 84, 64, 10.1002/ana.25264 · DOI · Paper page
- Moore, 2017, Evaluation of Antisense Oligonucleotides Targeting ATXN3 in SCA3 Mouse Models, Mol. Ther. Nucleic Acids, 7, 200, 10.1016/j.omtn.2017.04.005 · DOI · Paper page
- Toonen, 2016, Antisense oligonucleotide-mediated exon skipping as a strategy to reduce proteolytic cleavage of ataxin-3, Sci. Rep., 6, 35200, 10.1038/srep35200 · DOI
- Evers, 2013, Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: Removal of the CAG containing exon, Neurobiol. Dis., 58, 49, 10.1016/j.nbd.2013.04.019 · DOI
- Niu, 2018, Antisense oligonucleotides targeting mutant Ataxin-7 restore visual function in a mouse model of spinocerebellar ataxia type 7, Sci. Transl. Med., 10, eaap8677, 10.1126/scitranslmed.aap8677 · DOI · Paper page
- Yadava, 2021, Modeling muscle regeneration in RNA toxicity mice, Hum. Mol. Genet., 30, 1111, 10.1093/hmg/ddab108 · DOI
- Liu, 2021, Variant-selective stereopure oligonucleotides protect against pathologies associated with C9orf72-repeat expansion in preclinical models, Nat. Commun., 12, 847, 10.1038/s41467-021-21112-8 · DOI
- Toonen, 2017, Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 Mice, Mol. Ther. Nucleic Acids, 8, 232, 10.1016/j.omtn.2017.06.019 · DOI
- Kingwell, 2021, Double setback for ASO trials in Huntington disease, Nat. Rev. Drug Discov., 20, 412, 10.1038/d41573-021-00088-6 · DOI
- Yang, 2016, Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10, Nat. Commun., 7, 11647, 10.1038/ncomms11647 · DOI
Cited by
Castro, A. F., Figueiredo, A. S., Loureiro, J. R., Azevedo, M. M., Sampaio, P., Valentim, A. M., Bessa, J., & Silveira, I. (2026) · Disease Models & Mechanisms · doi:10.1242/dmm.052636 · Cited by 3
Self-citation
Metadata
- Authors
- Loureiro, J. R., Castro, A. F., Figueiredo, A. S., & Silveira, I.
- Affiliations
- Genetics of Cognitive Dysfunction Laboratory, i3S- Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2022-01-08
- Volume
- 11
- Issue
- 2
- Pages
- 205
- ISSN
- 2073-4409
- Cited by
- 28
- References
- 9
- Language
- en
- Funders
- Fundação para a Ciência e Tecnologia (POCI-01-0145-FEDER-029255 (PTDC/MED-GEN/29255/2017))
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Molecular Mechanisms in Pentanucleotide Repeat Diseases. https://app.cochat.ai/papers/10.3390/cells11020205
- The paper
- Loureiro, J. R., Castro, A. F., Figueiredo, A. S., & Silveira, I. (2022). Molecular Mechanisms in Pentanucleotide Repeat Diseases. Cells. https://doi.org/10.3390/cells11020205
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.